# BTM-3566 in Advanced Solid Tumors

Source: https://onco.cc/trials/nct07266285/  
OnCo record `nct07266285` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of BTM-3566 run by Bantam Pharmaceuticals, now recruiting.

## Summary

BTM-3566 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT07266285 by Bantam Pharmaceuticals, with 30 participants planned, started 2025-12-10. Conditions recorded: Advanced Solid Tumors. Interventions recorded: BTM-3566.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07266285
- Phase: 1
- Setting: A Phase 1 Trial of BTM-3566 in Advanced Solid Tumors
- Sponsor: Bantam Pharmaceuticals
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT07266285: https://clinicaltrials.gov/study/NCT07266285

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [BTM-3566](https://onco.cc/drugs/btm-3566/)
- companies: [Bantam Pharmaceutical](https://onco.cc/companies/bantam-pharmaceutical/)

---
JSON: https://onco.cc/api/v1/entities/nct07266285.json